Letrozole 2.5 MG tablet 90S
Ended Awarded
- Contract number
- SPE2DB25FRL40
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $1,082
Award facts
- Contract value 100% obligated
- $1,081.74 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 14, 2025, for the supply of Letrozole 2.5 mg tablets (90-count units) valued at $1,081.74. This firm fixed-price delivery order, with an ultimate completion date of July 15, 2025, represents a pediatric continuation under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999.999 billion through December 2026. The award involved no set-aside designation and was competitively awarded, reflecting the contractor's capability to meet federal pharmaceutical procurement requirements. The place of performance is listed as Conshohocken, Pennsylvania, AmerisourceBergen's corporate headquarters.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. As a prime contractor under the DLA's Pharmaceutical Prime Vendor Global Program, the company supplies a comprehensive range of pharmaceutical products across multiple therapeutic domains, including brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. This delivery order for Letrozole, a hormone therapy medication, exemplifies the company's role in supporting federal medical supply chains with firm fixed-price deliveries across transaction values ranging from under $100 to orders exceeding $45,000.
Quick answers
Who was awarded contract SPE2DB25FRL40?
SPE2DB25FRL40 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on July 14, 2025.
How much is contract SPE2DB25FRL40 worth?
The government has obligated $1,082 on SPE2DB25FRL40.
Is contract SPE2DB25FRL40 an order under another contract?
Yes. SPE2DB25FRL40 is a delivery order under SPE2DB22D3004, an indefinite delivery contract.
Was contract SPE2DB25FRL40 competed?
The extent of competition for SPE2DB25FRL40 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award